IL-27 Signaling Protects Against Influenza-Associated Pulmonary Aspergillosis Through Inhibition of Type 2 Immunity and Enhanced Antifungal Immunity
Preprint
Abstract
Influenza-associated pulmonary aspergillosis (IAPA) is a severe complication of influenza infection associated with substantial mortality. Influenza disrupts pulmonary host defenses and alters innate immune responses, predisposing patients to invasive fungal infection. Interleukin-27 (IL-27) is an immunoregulatory cytokine with context-dependent antiviral and antifungal effects; however, its role during IAPA remains undefined. A mouse model of IAPA was established by infecting wild-type and IL-27 receptor α-deficient ( Il27ra − / − ) mice with influenza A, followed by Aspergillus fumigatus challenge. IL-27 and IL-27Rα expression were increased during IAPA. Single-cell RNA sequencing identified monocytes as the primary source of IL-27 and T cells as major IL-27rα-expressing cells. Il27ra − / − mice exhibited significantly increased pulmonary fungal and influenza viral burden, enhanced type 2 immune responses characterized by elevated IL-4, IL-5, IL-9, IL-13, eosinophils, Th2 cells, pathogenic Th2 cells, and ILC2s. Despite increased eosinophil abundance, eosinophil-mediated conidial killing was impaired in Il27ra − / − mice. IL-27Rα deficiency also reduced macrophage abundance and impaired macrophage conidial uptake. Conversely, timed administration of rIL-27 enhanced fungal clearance, improved survival, and increased macrophage conidial uptake and augmented eosinophil killing capacity during IAPA. IL-27 signaling is a protective immunoregulatory cytokine during IAPA that limits pathological type 2 inflammation and enhances antifungal effector function of both eosinophils and macrophages. These findings identify IL-27 as a potential therapeutic in IAPA.Keywords
Funding Information
- National Institute of Allergy and Infectious Diseases (NIAID R01AI153337 (KMR))
This publication has 34 references indexed in Scilit:
- IL-27 elicits a cytotoxic CD8+ T cell program to enforce tumour controlNature, 2025
- Constitutive expression of interleukin-27 diminishes proinflammatory cytokine production without impairing effector function of engineered T cellsCytotherapy, 2023
- The JAK/STAT signaling pathway: from bench to clinicSignal Transduction and Targeted Therapy, 2021
- Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort studyThe Lancet Respiratory Medicine, 2018
- IL-27 suppresses type 2 immune responses in vivo via direct effects on group 2 innate lymphoid cellsMucosal Immunology, 2016
- Classical versus alternative macrophage activation: the Ying and the Yang in host defense against pulmonary fungal infectionsMucosal Immunology, 2014
- Tracing Conidial Fate and Measuring Host Cell Antifungal Activity Using a Reporter of Microbial Viability in the LungCell Reports, 2012
- Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysisThe Lancet, 2010
- The innate immune response to Aspergillus fumigatusMicrobes and Infection, 2009
- Identification of polymorphisms in human interleukin-27 and their association with asthma in a Korean populationJournal of Human Genetics, 2007